The present invention relates to a solid dosage form for oral administration comprising a therapeutically effective amount of Galantamine or a salt thereof incorporated in a matrix formed by a water soluble agent and a water insoluble agent. Said dosage form has adequate dissolution profile, bioavailability and stability and preferably consists of mini tablets filled in a hard gelatine capsule.
